Published in Am J Med on July 01, 2008
Complex formation with nucleic acids and aptamers alters the antigenic properties of platelet factor 4. Blood (2013) 1.56
Heparin enhances uptake of platelet factor 4/heparin complexes by monocytes and macrophages. J Thromb Haemost (2015) 1.41
Fondaparinux-associated heparin-induced thrombocytopenia. Proc (Bayl Univ Med Cent) (2012) 0.85
Heparin induced thrombocytopenia: case presentation and review. J Clin Med Res (2012) 0.80
Platelet factor 4/heparin antibodies in blood bank donors. Am J Clin Pathol (2010) 0.79
Emphasis on the Role of PF4 in the Incidence, Pathophysiology and Treatment of Heparin Induced Thrombocytopenia. Thromb J (2013) 0.79
Accelerated arterial and venous clots in a young pregnant woman: a saga of thrombotic storm. BMJ Case Rep (2013) 0.75
Spontaneous Heparin-Induced Thrombocytopenia and Venous Thromboembolism following Total Knee Arthroplasty. Case Rep Hematol (2017) 0.75
Drug-induced thrombocytopenia for the hospitalist physician with a focus on heparin-induced thrombocytopenia. Hosp Pract (1995) (2010) 0.75
Spontaneous heparin-induced thrombocytopenia presenting as bilateral adrenal hemorrhages and pulmonary embolism after total knee arthroplasty. Arthroplast Today (2015) 0.75
Anti-Platelet Factor 4/Heparin Antibody Formation Occurs Endogenously and at Unexpected High Frequency in Polycythemia Vera. Biomed Res Int (2017) 0.75
Guidelines on oral anticoagulation with warfarin - fourth edition. Br J Haematol (2011) 4.98
Acquired hemophilia A in the United Kingdom: a 2-year national surveillance study by the United Kingdom Haemophilia Centre Doctors' Organisation. Blood (2006) 3.71
Systematic review: efficacy and safety of rituximab for adults with idiopathic thrombocytopenic purpura. Ann Intern Med (2007) 2.97
Pityriasis rosea-like eruption associated with lamotrigine. J Am Acad Dermatol (2013) 2.59
An improved definition of immune heparin-induced thrombocytopenia in postoperative orthopedic patients. Arch Intern Med (2003) 1.70
Thrombin generation assays are superior to traditional tests in assessing anticoagulation reversal in vitro. Thromb Haemost (2008) 1.67
Enzymatically catalyzed disulfide exchange is required for platelet adhesion to collagen via integrin alpha2beta1. Blood (2003) 1.62
Enrichment of FLI1 and RUNX1 mutations in families with excessive bleeding and platelet dense granule secretion defects. Blood (2013) 1.60
Heparin-induced skin lesions and other unusual sequelae of the heparin-induced thrombocytopenia syndrome: a nested cohort study. Chest (2005) 1.49
Platelet transfusions in children: results of a randomized, prospective, crossover trial of plasma removal and a prospective audit of WBC reduction. Transfusion (2002) 1.44
The effect of rituximab on vaccine responses in patients with immune thrombocytopenia. Blood (2013) 1.44
Anti-platelet factor 4/heparin antibodies in orthopedic surgery patients receiving antithrombotic prophylaxis with fondaparinux or enoxaparin. Blood (2005) 1.43
Thrombotic thrombocytopenic purpura and hemolytic uremic syndrome: will recent insight into pathogenesis translate into better treatment? Transfusion (2002) 1.40
A retrospective 11-year analysis of obstetric patients with idiopathic thrombocytopenic purpura. Blood (2003) 1.38
Laboratory testing for the antibodies that cause heparin-induced thrombocytopenia: how much class do we need? J Lab Clin Med (2005) 1.38
Studies of the immune response in heparin-induced thrombocytopenia. Blood (2009) 1.37
Heparin-induced thrombocytopenia: diagnosis and management. Circulation (2004) 1.30
Congenital thrombophilic states associated with venous thrombosis: a qualitative overview and proposed classification system. Ann Intern Med (2003) 1.23
A pilot randomized trial of adjuvant rituximab or placebo for nonsplenectomized patients with immune thrombocytopenia. Blood (2012) 1.22
Approach to the diagnosis and management of drug-induced immune thrombocytopenia. Transfus Med Rev (2013) 1.20
Inhibitor development in haemophilia according to concentrate. Four-year results from the European HAemophilia Safety Surveillance (EUHASS) project. Thromb Haemost (2015) 1.20
Frequency of heparin-induced thrombocytopenia in critical care patients. Pharmacotherapy (2003) 1.16
Argatroban anticoagulation in patients with heparin-induced thrombocytopenia. Arch Intern Med (2003) 1.14
Misleading hepatitis B test results due to intravenous immunoglobulin administration: implications for a clinical trial of rituximab in immune thrombocytopenia. Transfusion (2010) 1.14
Rituximab maintenance for relapsed refractory thrombotic thrombocytopenic purpura. Transfusion (2012) 1.09
Heparin-induced thrombocytopenia in patients with ventricular assist devices: are new prevention strategies required? Ann Thorac Surg (2009) 1.07
Guidelines on the investigation and management of venous thrombosis at unusual sites. Br J Haematol (2012) 1.07
Treatment of heparin-induced thrombocytopenia: a critical review. Arch Intern Med (2004) 1.06
Heparin-induced thrombocytopenia and cardiac surgery. Ann Thorac Surg (2003) 1.03
Identification and characterization of a novel P2Y 12 variant in a patient diagnosed with type 1 von Willebrand disease in the European MCMDM-1VWD study. Blood (2009) 1.03
Diagnosis and management of neonatal alloimmune thrombocytopenia. Transfus Med Rev (2008) 1.01
IGIV-C, a novel intravenous immunoglobulin: evaluation of safety, efficacy, mechanisms of action, and impact on quality of life. Thromb Haemost (2004) 0.99
Sustained remissions of immune thrombocytopenia associated with the use of thrombopoietin receptor agonists. Transfusion (2013) 0.96
Blood product support for delivery in severe factor X deficiency: the use of thrombin generation to guide therapy. Blood Transfus (2007) 0.95
The IgG subclasses of platelet-associated autoantibodies directed against platelet glycoproteins IIb/IIIa in patients with idiopathic thrombocytopenic purpura. Br J Haematol (2003) 0.95
Platelet count response to H. pylori treatment in patients with immune thrombocytopenic purpura with and without H. pylori infection: a systematic review. Haematologica (2009) 0.95
Combination immunosuppressant therapy for patients with chronic refractory immune thrombocytopenic purpura. Blood (2009) 0.95
The role of interleukin-1 in allergy-related disorders. Curr Opin Allergy Clin Immunol (2012) 0.93
Current options for the treatment of idiopathic thrombocytopenic purpura. Semin Hematol (2007) 0.93
Skin corticotropin-releasing hormone receptor expression in psoriasis. J Invest Dermatol (2007) 0.92
Evaluation of the Roche LightCycler: a simple and rapid method for direct detection of factor V Leiden and prothrombin G20210A genotypes from blood samples without the need for DNA extraction. Blood Coagul Fibrinolysis (2003) 0.92
Acquired Glanzmann's thrombasthenia without thrombocytopenia: a severe acquired autoimmune bleeding disorder. Br J Haematol (2004) 0.91
Progression to end-stage liver disease in patients with inherited bleeding disorders and hepatitis C: an international, multicenter cohort study. Blood (2007) 0.91
Unfavourable cardiovascular disease risk profiles in a cohort of Dutch and British haemophilia patients. Thromb Haemost (2012) 0.89
Analyses of cellular multimerin 1 receptors: in vitro evidence of binding mediated by alphaIIbbeta3 and alphavbeta3. Thromb Haemost (2005) 0.88
IL-32 is increased along with tryptase in lesional psoriatic skin and is up-regulated by substance P in human mast cells. Eur J Dermatol (2010) 0.88
Recombinant Factor VIIa concentrate versus plasma derived concentrates for the treatment of acute bleeding episodes in people with haemophilia and inhibitors. Cochrane Database Syst Rev (2010) 0.86
A blinded study of bone marrow examinations in patients with primary immune thrombocytopenia. Eur J Haematol (2012) 0.85
Fatal spontaneous thrombosis of a cerebral arteriovenous malformation in a young patient with a rare heterozygous prothrombin gene mutation. Case report. J Neurosurg (2007) 0.83
Analgesic efficacy of valdecoxib for acute postoperative pain after bunionectomy. J Am Podiatr Med Assoc (2006) 0.82
Dissociation between the level of von Willebrand factor-cleaving protease activity and disease in a patient with congenital thrombotic thrombocytopenic purpura. Am J Hematol (2004) 0.82
Acute asthma exacerbations in childhood: risk factors, prevention and treatment. Expert Rev Respir Med (2012) 0.81
Nasal provocation of patients with allergic rhinitis and the hypothalamic-pituitary-adrenal axis. Ann Allergy Asthma Immunol (2007) 0.81
The impact of HIV on mortality rates in the complete UK haemophilia population. AIDS (2004) 0.81
Increased prevalence of hypertension in haemophilia patients. Thromb Haemost (2012) 0.81
New treatments for idiopathic thrombocytopenic purpura: rethinking old hypotheses. Expert Opin Investig Drugs (2009) 0.81
Argatroban anticoagulation in patients with a history of heparin-induced thrombocytopenia. Thromb Res (2004) 0.80
Pediatric allergic rhinitis and asthma: can the march be halted? Paediatr Drugs (2013) 0.80
Changes in bleeding patterns in von Willebrand disease after institution of long-term replacement therapy: results from the von Willebrand Disease Prophylaxis Network. Blood Coagul Fibrinolysis (2015) 0.79
IgE-mediated sensitization in seafood processing workers. Allergy Asthma Proc (2006) 0.79
An interpretative phenomenological analysis of adaptation to recurrent venous thrombosis and heritable thrombophilia: the importance of multi-causal models and perceptions of primary and secondary control. J Health Psychol (2008) 0.79
Bivalirudin: a review. Expert Opin Pharmacother (2005) 0.79
Differences in the clinically effective molar concentrations of four direct thrombin inhibitors explain their variable prothrombin time prolongation. Thromb Haemost (2005) 0.79
Inhibition of microsurgical thrombosis by the platelet glycoprotein IIb/IIIa antagonist SR121566A. Plast Reconstr Surg (2003) 0.79
Novel mutations of the HRAS gene and absence of hotspot mutations of the BRAF genes in oral squamous cell carcinoma in a Greek population. Oncol Rep (2012) 0.79
Rupatadine inhibits proinflammatory mediator secretion from human mast cells triggered by different stimuli. Int Arch Allergy Immunol (2009) 0.79
Fish and shellfish allergy in children: review of a persistent food allergy. Pediatr Allergy Immunol (2012) 0.78
Warfarin-associated multiple digital necrosis complicating heparin-induced thrombocytopenia and Raynaud's phenomenon after aortic valve replacement for adenocarcinoma-associated thrombotic endocarditis. Am J Hematol (2004) 0.78
Cognitive appraisals and psychological distress following venous thromboembolic disease: an application of the theory of cognitive adaptation. Soc Sci Med (2006) 0.77
Specific and global coagulation assays in the diagnosis of discrepant mild hemophilia A. Haematologica (2013) 0.77
HIT: lessons learned. Pathophysiol Haemost Thromb (2006) 0.77
A rapid, automated VWF ristocetin cofactor activity assay improves reliability in the diagnosis of Von Willebrand disease. Thromb Res (2010) 0.76
Key regulators of sensitization and tolerance: GM-CSF, IL-10, TGF-β and the Notch signaling pathway in adjuvant-free experimental models of respiratory allergy. Int Rev Immunol (2013) 0.76
Atopic Dermatitis, food allergy and dietary interventions. A tale of controversy. An Bras Dermatol (2013) 0.75
Rupatadine inhibits inflammatory mediator release from human laboratory of allergic diseases 2 cultured mast cells stimulated by platelet-activating factor. Ann Allergy Asthma Immunol (2013) 0.75
Inhibitor development in non-severe haemophilia across Europe. Thromb Haemost (2015) 0.75
Protein C deficiency screening using a thrombin generation assay - an upgrade. Thromb Haemost (2007) 0.75
Letter to the editor. J Foot Ankle Surg (2010) 0.75
Bleeding small bowel angiodysplasia in association with aortic stenosis: a role for combined wireless capsule endoscopy and push enteroscopy? J Clin Gastroenterol (2004) 0.75
Heparin-induced thrombocytopenia: an iceberg rising. Mayo Clin Proc (2005) 0.75
Unsuspected haemophilia in children with a single swollen joint. BMJ (2003) 0.75
History of non-fatal cardiovascular disease in a cohort of Dutch and British patients with haemophilia. Eur J Haematol (2012) 0.75
Images in haematology. Noonan syndrome associated with bleeding disorders. Br J Haematol (2010) 0.75
Depressive symptoms in urticaria patients treated with first- or second-generation histamine 1 receptor antagonists. J Clin Psychopharmacol (2007) 0.75
Effects of botulinum toxin-a therapy for palmar hyperhidrosis in plantar sweat production. Dermatol Surg (2010) 0.75
Non-immediate, severe hypersensitivity reaction to iopamidol with cross reactivity to different radiocontrast agents. Allergol Int (2013) 0.75
Transfer of the peroneus brevis tendon after resection of the fifth metatarsal base. J Am Podiatr Med Assoc (2004) 0.75
Hyperhomocysteinemia and venous thrombosis. Semin Hematol (2007) 0.75
Recombinant factor VIIa concentrate versus plasma-derived concentrates for treating acute bleeding episodes in people with haemophilia and inhibitors. Cochrane Database Syst Rev (2015) 0.75
Pattern of sensitization to honeybee venom in beekeepers: a 5-year prospective study. Allergy Asthma Proc (2006) 0.75
Cutaneous pseudolymphoma following administration of lornoxicam. Acta Derm Venereol (2007) 0.75
Theophylline as 'add-on' therapy to cetirizine in patients with chronic idiopathic urticaria. A randomized, double-blind, placebo-controlled pilot study. Int Arch Allergy Immunol (2006) 0.75
A review of randomized controlled trials using therapeutic apheresis. Transfus Med Rev (2002) 0.75
Food protein-induced enterocolitis syndrome: pitfalls in the diagnosis. Pediatr Allergy Immunol (2014) 0.75